Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Wu, Ning  [Clear All Filters]
2023
Zhang K, Wu N, Cen J, Li J, Wang Z, Xia Q, Hui L. Ex vivo factor VIII-modified proliferating human hepatocytes therapy for haemophilia A. Cell Prolif. 2023:e13467.
Yue K, Gao H, Liang S, Wu N, Cheng C, Xu L-P, Zhang X-H, Wang Y, Cheng Y, Huang X-J, et al. Improved Vδ2 T cells recovery correlates to reduced incidences of mortality and relapse in acute myeloid leukemia after hematopoietic transplantation. Ann Hematol. 2023.
Niu S, Xia C, Huang D, Wang L, Hu H, Yu S, Wu N, Dong Z, Zhou J, Wu J, et al. Requirements for human natural killer cells. Cell Prolif. 2023:e13588.
2022
Yu Y, Zhang Q, Wu N, Xia L, Cao J, Xia Q, Zhao J, Zhang J, Hang H. HNF4α overexpression enhances the therapeutic potential of umbilical cord mesenchymal stem/stromal cells in mice with acute liver failure. FEBS Lett. 2022.
Jalbert JJ, Wu N, Chen C-I, Ambati S, Ge W, Arnason JE. Real-World Treatment Patterns After CD19-Directed CAR T Cell Therapy Among Patients with Diffuse Large B Cell Lymphoma. Adv Ther. 2022.
2020
Liu J, Gao H, Xu L-P, Mo X-D, Liu R, Liang S, Wu N, Wang M, Wang Z, Chang Y-J, et al. Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2 T cells activities after hematopoietic transplantation for blood malignancies. J Immunother Cancer. 2020;8(1).
2016
Wu N, Zhang Y-L, Wang H-T, Li D-W, Dai H-J, Zhang Q-Q, Zhang J, Ma Y, Xia Q, Bian J-M, et al. Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation. Cancer Biol Ther. 2016.
2014
Hang H, Yu Y, Wu N, Huang Q, Xia Q, Bian J. Induction of Highly Functional Hepatocytes from Human Umbilical Cord Mesenchymal Stem Cells by HNF4α Transduction. PLoS One. 2014;9(8):e104133.
Wu N, Gidrol X. The wind rose of human keratinocyte cell fate. Cell Mol Life Sci. 2014.